PwC remains committed to helping clients explore opportunities in the new science of Personalized Medicine by publishing thoughtful research identifying innovations designed to customize care and move toward a predictive, preventive, participatory and personalized healthcare system.
In the fall and winter of 2009, PwC published Diagnostics 2009 and The new science of personalized medicine. These reports provide insights into how investment and innovation are shaping the health industries. In the spring of 2010 PwC published HealthCast and The impact of personalized medicine today. These reports focus on the impact personalized medicine will have in providing patient-centric care.
The impact of personalized medicine today
Personalized medicine is where genetic testing, health IT, and patient-centered care intersect and where high-value healthcare will live in the foreseeable future. In this report, leading hospital systems — Beth Israel Deaconess Medical Center, The Ohio State University Medical Center, Partners HealthCare, and Vanderbilt University Medical Center — share their insights and the lessons learned.
HealthCast: The customization of diagnosis, care and cure
Between now and 2020, health systems will turn from reactive medicine to proactively understanding and supporting individuals in managing their own health. Many health systems say they deliver patient-centered care, but PwC’s research found only pockets in which this is evidenced. Health organizations remain too focused on their own organizations, not what’s best for the patient. Patient-centered care takes health systems out of their comfort zones, forcing them to integrate people, technologies and organizations that are not part of their current routines.
The new science of personalized medicine: Translating the promise into practice
The advent of personalized medicine, which targets individualized treatment and care based on personal and genetic variation, is creating a booming market that is bigger than most may realize. But personalized medicine is a disruptive innovation that creates both opportunities and challenges for traditional healthcare and emerging new market participants.
Diagnostics 2009: Moving towards personalized medicine
This report reviews the flurry of deal activity in the past few years in the in vitro diagnostics (IVD) sector and discusses significant events for personalized medicine, a field which is fast rising to prominence in healthcare innovation. Topics covered include M&A and licensing deal activity, regulatory developments on biomarker testing, partnerships with the pharmaceutical industry, significant events beyond deal activity, case studies and key drivers of future revenue growth for personalized medicine diagnostics.
Personalized Medicine and Health Sciences Leader
Personalized Medicine and Health Sciences Practice